Pharmaceutical Lifecycle Management – Making the Most of Each and Every Brand
Autor T Elleryen Limba Engleză Hardback – 14 iun 2012
Preț: 613.99 lei
Preț vechi: 667.38 lei
-8% Nou
Puncte Express: 921
Preț estimativ în valută:
117.52€ • 122.22$ • 98.48£
117.52€ • 122.22$ • 98.48£
Carte tipărită la comandă
Livrare economică 13-27 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780470487532
ISBN-10: 0470487534
Pagini: 412
Dimensiuni: 152 x 234 x 23 mm
Greutate: 0.73 kg
Editura: Wiley
Locul publicării:Hoboken, United States
ISBN-10: 0470487534
Pagini: 412
Dimensiuni: 152 x 234 x 23 mm
Greutate: 0.73 kg
Editura: Wiley
Locul publicării:Hoboken, United States
Public țintă
Pharmaceutical executives and managers, including the following: Drug company CEO′s, Heads of Development and Marketing, Development Project Leaders and Project Teams, Brand Directors and Brand TeamsFormulations scientists, drug regulatory affairs managers, patent and IP professionals
Consultants, trainers, and contract research organizations (CROs)
Cuprins
Notă biografică
TONY ELLERY is a consultant with Ellery Pharma Consulting. Until September 2008, he was the Head of Pharmaceutical Lifecycle Management in Portfolio Management at Novartis AG. Prior to this, he occupied positions of increasing seniority in research, development, and marketing at different companies, including Roche, Ciba Vision, and Novartis. Dr. Ellery has served as a member of the Ciba-Geigy Research Advisory Board and the Novartis Pharma Development Management Board. He is a popular speaker on lifecycle, project, and portfolio management. NEAL HANSEN is the Managing Director of Healthcare Consulting within the Informa Group, encompassing Datamonitor Healthcare Consulting and Phasic Strategy. Previously, he was the European Head of Consulting within Wood Mackenzie's Life Sciences Practice. He works with many key players in the pharmaceutical industry to support effective decision making for brand and portfolio strategy and has chaired and spoken at numerous conferences in the field of lifecycle management and the changing nature of the generic drug industry.
Descriere
This book systematically explains how LCM strategies can help the pharmaceutical industry maximize the value of its patented brands through effective drug development programs and brand management.